Pds biotech to participate at the b. riley securities 3rd annual oncology conference

Florham park, n.j., jan. 13, 2023 (globe newswire) -- pds biotechnology corporation (nasdaq: pdsb), a clinical-stage immunotherapy company developing a growing pipeline of targeted immunotherapies for cancer and infectious disease, today announced that its management will participate in a fireside chat at the b. riley securities 3rd annual oncology conference being held virtually on january 18-19, 2023.
PDSB Ratings Summary
PDSB Quant Ranking